Results 131 to 140 of about 186,717,015 (170)

The study of biosafety risk identification and analysis for facilities in biosafety level 3 laboratories. [PDF]

Front Cell Infect Microbiol
Lv B, Zhou Z, Wang J, Niu Q, Shi Y, Sun Y, Zhao H, Lu D, Fan T, Huang Y.   +9 more
europepmc   +1 more source

Validation of Chemical Inactivation Protocols for <i>Henipavirus</i>-Infected Tissue Samples. [PDF]

Viruses
Silva-Ayala D, Griffiths A.
europepmc   +1 more source

Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis. [PDF]

Animal Model Exp Med
Jia Y, Guo Y, Yang Y, Zhang J, Zhang Z, Qu Y, Tan J, Shen J, Limjunyawong N, Xu J, Zhang Z, Luo F, Dou C.   +12 more
europepmc   +1 more source

Prion seeding activity in DNA extractions: implications for laboratory biosafety. [PDF]

Prion
Gresch SC, Morrill T, Ellis-Cramer M, Arifin M, Frank LE, Bartz JC, Schwabenlander MD, Wolf TM, Mitchell GB, Guan J, Larsen PA.   +10 more
europepmc   +1 more source

Cartridge-based sequencing for bedaquiline resistance detection from sputum. [PDF]

IJTLD Open
Limberis JD, Nagel RJ, Block D, Colman RE, Nalyvayko A, Howard Z, Dewell S, Chakravorty S, Metcalfe JZ.   +8 more
europepmc   +1 more source

Harnessing Hazara Virus as a Surrogate for Crimean-Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level. [PDF]

Pathogens
Olejnik J, Meier K, Herrera JN, DeStasio DJ, Deeney DJ, Flores EY, White MR, Hume AJ, Mühlberger E.   +8 more
europepmc   +1 more source

Approaches for inactivating highly pathogenic avian influenza H5N1 cattle isolate for safe containment level 2 laboratory practices. [PDF]

Appl Environ Microbiol
Aubrey L, Barron-Castillo U, Berube N, Pessoa N, Macas Jacome L, Trann J, Gentes A, Van Kessel J, Warner B, Facciuolo A, Zhou Y.   +10 more
europepmc   +1 more source

Biomedical optics: illuminating paths to enhance health equity in the Philippines. [PDF]

Biomed Opt Express
Perez PNG, Calpito KJAC, Jimenez SJA.
europepmc   +1 more source

Inactivation of Ebola, Nipah, and Lassa viruses in tissue using neutral buffered formalin, MagMAX lysis/binding solution, or TriPure isolation reagent. [PDF]

Sci Rep
Davies KA, Welch SR, Harcourt BH, Spiropoulou CF, Spengler JR.   +4 more
europepmc   +1 more source

Microalgae for bioremediation: advances, challenges, and public perception on genetic engineering. [PDF]

BMC Plant Biol
Calatrava V, Gonzalez-Ballester D, Dubini A.   +2 more
europepmc   +1 more source